Skip to main content
DCGO logo

DocGo Inc. (DCGO) Stock Price & Analysis

DocGo Inc. (DCGO) — MoonshotScore 22/100 (Weak band), calculated Nov 18, 2026. Price $0.175 (+1.98%), as of the Nov 20, 2026 trading session; market cap $17.3M.

Educational signal · not a buy or sell recommendation · How to read this

$0.175 +$0.0034 (+1.98%) Market Cap $17.3M

DocGo Inc. · DCGO · NASDAQ

DocGo Inc. provides mobile health and medical transportation services in the United States and the United Kingdom.

Price as of Nov 20, 2026

Key Statistics

22 of 100

MoonshotScore v2 · DocGo (DCGO)

Weak
Business Quality Thin (31)
Financial Safety Okay (41)
Valuation Fair (68)
Growth Durability Shrinking (13)
Momentum Slipping (20)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Weak quality and stalling growth, though the balance sheet is only middling, and the price trend has turned against it. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Thin; Financial Safety: Okay; Valuation: Fair; Growth Durability: Shrinking; Momentum: Slipping.

  • quarterly revenue $73M (Q3 FY2026, quarter ended Sep 30, 2026)
  • EPS beat 0 of the last 8 reports
  • Altman Z -2.94 · Piotroski F 5

Holding back: weak fundamentals, soft growth, weak price trend

Helping: an attractive price

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for DCGO (58 recorded, newest six shown)
RecordedScoreBand
21Weak
21Weak
21Weak
22Weak
22Weak
22Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.175
Change on the day+1.98%
52-week range$0.175 – $1.10
Market capitalisation$17.3M—
Shares traded on the day1.02M

Price & events

Other perspectives

Council score for DocGo (DCGO): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Weak
Financial Safety Neutral
Valuation Moderate
Growth Durability Negative
Momentum Weak

Legends Council

3 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Unfavorable read

Read on: Nov 15, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Undervalued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Moderate
ROE Negative
Gross Margin Neutral

Read on: Oct 15, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Oct 15, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is DocGo (DCGO), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. DocGo Inc. (DCGO) is listed on NASDAQ. It employs 3,568 people and is led by Lee Bienstock. In Q3 FY2026 it reported revenue of $73M and net income of -$17M. The market values it at $17.3M.

2 · Latest results

What do the latest results show for DocGo (DCGO)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $73M. Against analyst estimates the company has EPS beat 0 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$73M-$17M-$0.17 (diluted)
Q2 FY2026$73M-$16M-$0.16 (diluted)
Q1 FY2026$76M-$15M-$0.15 (diluted)
Q4 FY2025$75M-$134M-$1.37 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for DocGo (DCGO)?

Short answer · as of

The MoonshotScore pillars rate an attractive price as strengths. What is holding it back is weak fundamentals, soft growth, weak price trend. The distress and quality screens read Altman Z -2.94 · Piotroski F 5. Trailing ratios: current ratio 1.38.

Data-derived red flags

  • Listing risk — at $0.175 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.
  • Financial-distress signal — its Altman Z-Score of -2.94 sits in the distress zone (elevated bankruptcy risk).
  • Inconsistent delivery — missed Wall Street EPS estimates in 8 of the last 8 reported quarters.
4 · What to check next?

What should you watch next at DocGo (DCGO)?

Short answer · as of

The stored analyst-target capture is expired, so a current target watchpoint is unavailable.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does DocGo compare with its peers?

Short answer

DocGo's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
AMN Healthcare Services, Inc. (AMN) Same industry, near in market value$35.68 Nov 20, 2026$1.38B93 5-pillar Nov 18, 2026
InnovAge Holding Corp. (INNV) Same industry, near in market value$9.16 Nov 20, 2026$1.25B92 5-pillar Nov 18, 2026
Astrana Health, Inc. (ASTH) Same industry, near in market value$28.90 Nov 20, 2026$1.44B80 5-pillar Nov 18, 2026
The Joint Corp. (JYNT) Same industry, near in market value$6.19 Nov 20, 2026$84.7M73 5-pillar Nov 18, 2026
The Pennant Group, Inc. (PNTG) Same industry, near in market value$34.64 Nov 20, 2026$1.22B68 5-pillar Nov 18, 2026
U.S. Physical Therapy, Inc. (USPH) Same industry, near in market value$95.93 Nov 20, 2026$1.43B63 5-pillar Nov 18, 2026
Auna S.A. (AUNA) Same industry, near in market value$3.66 Nov 20, 2026$271M59 5-pillar Nov 18, 2026
Community Health Systems, Inc. (CYH) Same industry, near in market value$1.62 Nov 20, 2026$228M52 5-pillar Nov 18, 2026
biote Corp. (BTMD) Same industry, near in market value$0.81 Nov 20, 2026$26.3M39 5-pillar Nov 18, 2026
Agilon Health, Inc. (AGL) Same industry, near in market value$90.24 Nov 20, 2026$1.52B36 5-pillar Nov 18, 2026
Cryo-Cell International, Inc. (CCEL) Same industry, near in market value$4.15 Nov 20, 2026$33.5M33 5-pillar Nov 18, 2026
AirSculpt Technologies, Inc. (AIRS) Same industry, near in market value$0.59 Nov 20, 2026$43.7M33 5-pillar Nov 18, 2026
DocGo (DCGO) — this page$0.175$17.3M22

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Last captured analyst target range, low to high (expired, captured Nov 11, 2026)
$1.50 – $11.00
Last captured analyst target (expired, captured Nov 11, 2026)
$5.84
Last captured median analyst target (expired, captured Nov 11, 2026)
$5.43

Historical target record · Captured · Capture expired; not a current watchpoint.

Insider activity

Form 4 records via FMP · Most recent available transactions

Transactions
12
Identified insiders
6
Purchases
0
Sales
1
Other transactions
11

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held DCGO in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported DCGO in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about DocGo (DCGO)?

Read these with our analysis →

DocGo Stock: Key Questions Answered

These answers are editorial: 1 of these 9 answers is drawn from the DCGO research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for DCGO?

DCGO carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is DCGO a good stock to buy?

Stock Expert AI does not rate DCGO buy, sell or hold. DocGo Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the DCGO stock price today?

The last price recorded for DocGo Inc. (DCGO), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the DCGO price target?

The last analyst consensus price target we captured for DocGo Inc. (DCGO), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.

What do analysts say about DCGO stock?

Analyst coverage of DocGo Inc. is limited, but existing reports suggest a mixed outlook. Some analysts highlight the company's growth potential in the mobile health market, while others express concerns about its profitability and competitive landscape.

What are the key factors to evaluate for DCGO?

DocGo Inc. (DCGO) holds a MoonshotScore in the low range. DocGo operates in the mobile health and medical transportation sector, providing services in the US and UK. Not financial advice.

How frequently does DCGO data refresh on this page?

DCGO's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven DCGO's recent stock price performance?

DocGo Inc. (DCGO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative mobile health platform. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider DCGO overvalued or undervalued right now?

DocGo Inc. (DCGO) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 19 figures on this page — 11 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.